0001680581-16-000001.txt : 20160725 0001680581-16-000001.hdr.sgml : 20160725 20160725094212 ACCESSION NUMBER: 0001680581-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160725 DATE AS OF CHANGE: 20160725 EFFECTIVENESS DATE: 20160725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-267612 FILM NUMBER: 161781192 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 700, SUITE B7102 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 700, SUITE B7102 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0707 D LIVE 0001680581 Fulcrum Therapeutics, Inc. ONE KENDALL SQUARE BUILDING 700, SUITE B7102 CAMBRIDGE MA MASSACHUSETTS 02139 617-651-8851 DELAWARE None None Corporation true 2015 Robert Gould One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Mark Levin One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Director James Geraghty One Kendall Square Building 700, Suite B7102 Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2016-07-18 true true false 0 55000000 17000000 38000000 false 1 0 0 0 false Fulcrum Therapeutics, Inc. /s/ Robert Gould Robert Gould President and Chief Executive Officer 2016-07-22